Table 1.
All participants (n = 2477) | Participants who completed clinical assessment and provided full data (n = 194) | |
---|---|---|
Female, n (%, 95% CI) | 1549, (63, 61, 65) | 122, (63, 56, 70) |
Age, median (IQR) | 64 (55–74) | 66.5 (59–78) |
Fatigue (CFQ, 0–33), median (IQR) (n=2272) | 12 (11–16) | 12 (11–16) |
MSK Pain (number of sites 0–29), median (IQR) (n=2463) | 3 (0–8) | 3 (0–6) |
Depression (HADS; 0–21), median (IQR) (n=2285) | 4 (2–7) | 4 (2–7) |
Anxiety (HADS; 0–21), median (IQR) (n=2271) | 5 (2–8) | 5 (2–7) |
Sub-optimal PA, n (%, 95% CI) (n=2346) | 1278 (55, 53, 57) | 112, (58, 51, 65) |
Number of current medications, median (IQR) | 2 (0–5) | 3 (1–5) |
WUR-H, median (IQR) | — | 2.3 (1.5, 4.0) |
WUR-F, median (IQR) | — | 2.4 (1.6, 3.9) |
% Body fat, median (IQR) | — | 31.8 (25.1–38.5) |
95% CI: 95% confidence interval; CFQ: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; RAPA: Rapid Assessment of Physical Activity; IQR: interquartile range; MSK: musculoskeletal; WUR-H: wind-up ratio test at the hand; WUR-F: wind-up ratio test at the foot; PAALS: Pain Across the Adult Life Span; PA: Physical Activity.